Wolters Kluwer Health Transitions the Journal Medicine to Fully Open Access, Broad-Based Biomedical Title in 2015
Medicine’s Highly Respected Editorial Board Now Accepting Open Access Content
Article ID: 613325
Released: 5-Feb-2014 10:00 AM EST
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — New York, NY (February 5, 2014) – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, today announced that Medicine, one of the most respected and frequently cited journals in general medicine, will transition to an open access publication from a subscription-based model. Medicine will provide authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. In addition, Medicine will provide author tools for ongoing promotion of published articles and data on article usage. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines. Medicine is indexed in MEDLINE® with an Impact Factor of 4.233 based on the latest Journal Citation Reports® (ranking 18th in General & Internal Medicine specialty).
“Providing our partners, authors, and readers with greater access and distribution options to peer-reviewed content is essential to how medical content is consumed by practitioners today. Open access publishing strategies are part of this channel mix,” said Jayne Marks, Vice President Publishing, Wolters Kluwer Health, Medical Research.
Medicine will continue to offer subscribers a complete volume of content for 2014, while accepting submissions under the new open access model. The journal will transition from subscription to a fully open access title in 2015. Open access articles in Medicine will be freely available to read, download, and share from the time of publication. Articles will be published under the terms of the Creative Commons License 4.0, which enables authors to retain copyright while allowing others to copy, distribute, and make some uses of their work. Medicine will use article payment charges (APCs), applied to accepted manuscripts only. The APC covers the cost of the publication process, including peer-reviewing, editing, publishing, maintaining, and archiving.
Medicine® provides insight from leading scholars about the latest results in clinical investigation. Relevant to both hospital and office practice, the journal currently includes analytical reviews of Internal Medicine, Dermatology, Neurology, Pediatrics, and Psychiatry topics. Articles typically include original patient data from the author's own experience along with a scholarly review of the literature.
Medicine® also offers follow-up studies, practice-oriented reports of clinical observations, and "Reviews in Molecular Medicine," monographs that focus on how the "new genetics" and genomics have altered understanding and management of a particular disorder. It is one of the most respected and frequently cited journals in the field.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.